The United States market has shown a positive trend, climbing 1.6% in the last week and 21% over the past year, with earnings forecasted to grow by 19% annually. For investors interested in exploring beyond well-known stocks, penny stocks—typically representing smaller or newer companies—can present intriguing opportunities despite their somewhat outdated label. By focusing on those with strong financial health and potential for growth, investors can uncover valuable opportunities among these lesser-known names.

Underneath we present a selection of stocks filtered out by our screen.

GoodRx Holdings (GDRX)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: GoodRx Holdings, Inc., along with its subsidiaries, provides tools and information for consumers to compare prices and save on prescription drugs in the United States, with a market cap of approximately $975.39 million.

Operations: The company generates revenue primarily from its Healthcare Software segment, which amounted to $787.89 million.

Market Cap: $975.39M

GoodRx Holdings, Inc. operates within the healthcare software sector, generating US$787.89 million in revenue with a market cap of approximately US$975.39 million. The company has reduced its debt to equity ratio over five years but still faces challenges covering interest payments with earnings. Despite a decline in net profit margins and negative earnings growth, GoodRx's short-term assets exceed liabilities, indicating financial stability. Recent initiatives like the launch of GoodRx Companion aim to diversify revenue streams through subscription models for healthcare savings, potentially enhancing consumer engagement and creating more predictable income beyond traditional prescription transactions.

CI&T (CINT)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: CI&T Inc. offers strategy, design, and software engineering services globally, with a market cap of $429.30 million.

Operations: The company generates revenue of $515.38 million from its computer services segment.

Market Cap: $429.3M

CI&T Inc., with a market cap of US$429.30 million, has shown robust financial health and growth potential within the IT sector. It trades at 25.3% below estimated fair value and has improved net profit margins, now at 7.9%. The management team is experienced with an average tenure of 3.3 years, contributing to stable operations reflected in consistent earnings growth—25.7% over the past year, surpassing industry averages. Recent earnings guidance revisions indicate anticipated revenue between US$555.8 million and US$575.3 million for 2026, bolstered by favorable foreign exchange impacts and strategic share buybacks enhancing shareholder value without significant dilution concerns.

Snap (SNAP)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Snap Inc. is a technology company that operates in North America, Europe, and internationally with a market capitalization of approximately $7.36 billion.

Operations: The company generates revenue of $6.10 billion from its Software & Programming segment.

Market Cap: $7.36B

Snap Inc., with a market cap of US$7.36 billion, is navigating complex challenges while demonstrating potential growth in the tech sector. Despite being unprofitable, Snap's revenue of US$6.10 billion and positive free cash flow provide a cash runway exceeding three years. Recent legal issues, including lawsuits related to its platform's safety for minors, present significant risks. However, strategic initiatives like the launch of SPECS AR glasses and partnerships such as Sprout Social integration aim to enhance user engagement and brand reach. The company has also reduced its net loss from previous years and maintains satisfactory debt levels relative to equity.

Turning Ideas Into Actions

• Unlock our comprehensive list of 316 US Penny Stocks by clicking here.
• Want To Explore Some Alternatives? This technology could replace computers: discover the 26 stocks are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.